Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(435)
•••
Post by Oilersgoforcupon Aug 13, 2020 11:36am
260 Views
Post# 31403441

Like is said the Engines are just warming up...

Like is said the Engines are just warming up...Everyone is hoping to grab shares on a dip.  Good luck.  Why would you want to sell with everythign that is going on ?  Next week Tripp will unleash the hounds and everyone will start panic buying.  Todays prices are still bargain basement, i cannot belive we are not at our 52 week high yet, but thats what happens when day traders(penny flippers) getting involved.  So buy today, be patient and your patience will be rewarded.  Always do you own DD, and good luck to all !!

https://www.cantechletter.com/2020/08/stagezero-life-sciences-has-a-massive-upside-clarus-securities-says/

https://markets.businessinsider.com/analyst/stagezero_life_sciences?op=1

https://www.alpharetta.ga.us/community/news/2020/05/20/alpharetta-first-georgia-city-to-provide-antibody-testing-to-emergency-responders

https://canadianwarrants.com/values/current.htm#axzz6UuhJh4Tf

/press-release/stagezero-life-sciences-partners-with-udotest-to-link-physicians-and-their-patients-to-urgent-covid-19-testing-2020-05-19






Bullboard Posts
Dealroom for high-potential pre-IPO opportunities